BMRA · Biomerica Inc
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Apr 13, 2026
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2025-12-12 | Irani Zackary S. |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Common stock (Direct)
Award of restricted stock under the 2024 Stock Incentive Plan. The award of restricted stock will vest over 4 years at 25% on each anniversary of December 12, 2025, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. |
Common stock
|
52,500 |
| 2025-12-12 | BARBIERI ALLEN |
Director, Executive Vice-Chairman |
Award↑
Filing footnotes — Common stock (Direct)
Award of restricted stock under the 2024 Stock Incentive Plan. The award of restricted stock will vest in full on the one-year anniversary of December 12, 2025, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. |
Common stock
|
30,000 |
| 2025-12-12 | Gary M. Huff |
Director |
Award↑
Filing footnotes — Common stock (Direct)
Award of restricted stock under the 2024 Stock Incentive Plan. The award of restricted stock will vest in full on the one-year anniversary of December 12, 2025, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. |
Common stock
|
20,000 |
| 2025-12-12 | MOATAZEDI DAVID |
Director |
Award↑
Filing footnotes — Common stock (Direct)
Award of restricted stock under the 2024 Stock Incentive Plan. The award of restricted stock will vest in full on the one-year anniversary of December 12, 2025, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. |
Common stock
|
20,000 |
| 2025-12-12 | Lu Gary |
Chief Financial Officer |
Award↑
Filing footnotes — Common stock (Direct)
Award of restricted stock under the 2024 Stock Incentive Plan. The award of restricted stock will vest over 4 years at 25% on each anniversary of December 12, 2025, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. |
Common stock
|
40,000 |
| 2025-12-12 | Chin Eric |
Director |
Award↑
Filing footnotes — Common stock (Direct)
Award of restricted stock under the 2024 Stock Incentive Plan. The award of restricted stock will vest in full on the one-year anniversary of December 12, 2025, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. |
Common stock
|
22,500 |
| 2024-12-13 | Emerson Jane |
Director |
Award↑
Filing footnotes — Common stock (Direct)
Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of December 13, 2024, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. |
Common stock
|
85,000 |
| 2024-12-13 | Irani Zackary S. |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Common stock (Direct)
Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over 4 years at 25% on each anniversary of December 13, 2024, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. |
Common stock
|
250,000 |
| 2024-12-13 | MOATAZEDI DAVID |
Director |
Award↑
Filing footnotes — Common stock (Direct)
Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of December 13, 2024, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. |
Common stock
|
85,000 |
| 2024-12-13 | Lu Gary |
Chief Financial Officer |
Award↑
Filing footnotes — Common stock (Direct)
Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over 4 years at 25% on each anniversary of December 13, 2024, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. |
Common stock
|
155,000 |
| 2024-12-13 | Coste Catherine |
Director |
Award↑
Filing footnotes — Common stock (Direct)
Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of December 13, 2024, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. |
Common stock
|
85,000 |
| 2024-12-13 | BARBIERI ALLEN |
Director, Executive Vice-Chairman |
Award↑
Filing footnotes — Common stock (Direct)
Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of December 13, 2024, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. |
Common stock
|
110,000 |
| 2023-12-13 | MOATAZEDI DAVID |
Director |
Award↑
Filing footnotes — Non-qualified stock option (Direct)
Options granted to Ms. Coste as part of her Fiscal 2024 Board compensation package. Not Applicable |
Non-qualified stock option
|
75,000 |
| 2023-12-13 | Emerson Jane |
Director |
Award↑
Filing footnotes — Non-qualified stock option (Direct)
Options granted to Ms. Coste as part of her Fiscal 2024 Board compensation package. Not Applicable |
Non-qualified stock option
|
75,000 |
| 2023-12-13 | BARBIERI ALLEN |
Director, Executive Vice-Chairman |
Award↑
Filing footnotes — Non-qualified stock option (Direct)
Options granted to Ms. Coste as part of her Fiscal 2024 Board compensation package. Not Applicable |
Non-qualified stock option
|
100,000 |
| 2023-12-13 | Coste Catherine |
Director |
Award↑
Filing footnotes — Non-qualified stock option (Direct)
Options granted to Ms. Coste as part of her Fiscal 2024 Board compensation package. Not Applicable |
Non-qualified stock option
|
75,000 |
| 2023-12-13 | Lu Gary |
Chief Financial Officer |
Award↑
Filing footnotes — Non-qualified stock option (Direct)
Options granted to Mr. Lu as part of his Fiscal 2024 executive compensation package. Not Applicable 25% vesting on 12/013/2024, 25% on 12/13/2025, 25% on 12/13/2026, and 25% on 12/13/2027 |
Non-qualified stock option
|
155,000 |
| 2023-12-13 | Irani Zackary S. |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Non-qualified stock option (Direct)
Options granted to Mr. Irani as part of his Fiscal 2024 Board compensation package. Not Applicable 25% vesting on 12/013/2024, 25% on 12/13/2025, 25% on 12/13/2026, and 25% on 12/13/2027 |
Non-qualified stock option
|
155,000 |
| 2023-12-13 | Kenny John P. |
Director |
Award↑
Filing footnotes — Non-qualified stock option (Direct)
Options granted to Ms. Coste as part of her Fiscal 2024 Board compensation package. Not Applicable |
Non-qualified stock option
|
75,000 |
| 2023-08-29 | Kenny John P. |
Director |
Award↑
Filing footnotes — Non-qualified stock option (Direct)
Options granted to Mr. Kenny in August 2023 as a new Board member. Final issuance of the options was subject to and conditioned upon the approval by stockholders of the 2023 Stock Incentive Plan, which occured on December 7, 2023. Not Applicable 25% vesting on 12/7/2023, 25% on 12/07/2024, 25% on 12/07/2025 and 25% on 12/07/2026 |
Non-qualified stock option
|
30,000 |
| 2023-05-25 | Irani Zackary S. |
Director, Chief Executive Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
Open Market Purchase |
Common Stock
|
200 |
| 2023-05-24 | Irani Zackary S. |
Director, Chief Executive Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
Open Market Purchase |
Common Stock
|
500 |
| 2023-05-12 | Irani Zackary S. |
Director, Chief Executive Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
Open Market Purchase |
Common Stock
|
1,700 |
| 2023-05-10 | Irani Zackary S. |
Director, Chief Executive Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
Open Market Purchase |
Common Stock
|
500 |
| 2023-05-09 | Irani Zackary S. |
Director, Chief Executive Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
Open Market Purchase |
Common Stock
|
300 |
| 2023-05-04 | Irani Zackary S. |
Director, Chief Executive Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
Open Market Purchase |
Common Stock
|
1,000 |
| 2023-04-28 | Irani Zackary S. |
Director, Chief Executive Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
Open Market Purchase |
Common Stock
|
1,800 |
| 2023-04-27 | Irani Zackary S. |
Director, Chief Executive Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
Open Market Purchase |
Common Stock
|
2,600 |
| 2023-04-26 | Irani Zackary S. |
Director, Chief Executive Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
Open Market Purchase |
Common Stock
|
7,000 |
| 2023-04-20 | Emerson Jane |
Director |
Award↑
Filing footnotes — Non-qualified stock option (Direct)
Options granted to Ms. Emerson in April 2023 as part of her fiscal 2023 Board compensation package. Final issuance was subject to and conditioned upon the approval by stockholders of the 2023 Stock Incentive Plan, which occured on December 7, 2023. Not Applicable |
Non-qualified stock option
|
32,000 |
| 2023-04-20 | MOATAZEDI DAVID |
Director |
Award↑
Filing footnotes — Non-qualified stock option (Direct)
Options granted to Mr. Moatazedi in April 2023 as part of his fiscal 2023 Board compensation package. Final issuance was subject to and conditioned upon the approval by stockholders of the 2023 Stock Incentive Plan, which occured on December 7, 2023. Not Applicable |
Non-qualified stock option
|
32,000 |
| 2023-04-20 | Irani Zackary S. |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Non-qualified stock option (Direct)
Options granted to Mr. Irani in April 2023 as part of his fiscal 2023 Board compensation package. Final issuance was subject to and conditioned upon the approval by stockholders of the 2023 Stock Incentive Plan, which occured on December 7, 2023. Not Applicable 25% vesting on 12/07/2023, 25% on 12/07/2024, 25% on 12/07/2025 and 25% on 12/07/2026 |
Non-qualified stock option
|
105,000 |
| 2023-04-20 | MOATAZEDI DAVID |
Director |
Award↑
Filing footnotes — Non-qualified stock option (Direct)
Options granted to Mr. Moatazedi in April 2023 as a new Board member. Final issuance of the options was subject to and conditioned upon the approval by stockholders of the 2023 Stock Incentive Plan, which occured on December 7, 2023. Not Applicable 25% vesting on 12/7/2023, 25% on 12/07/2024, 25% on 12/07/2025 and 25% on 12/07/2026 |
Non-qualified stock option
|
25,000 |
| 2023-04-20 | BARBIERI ALLEN |
Director, Executive Vice-Chairman |
Award↑
Filing footnotes — Non-qualified stock option (Direct)
Options granted to Mr. Barbieri in April 2023 as part of his fiscal 2023 Board compensation package. Final issuance was subject to and conditioned upon the approval by stockholders of the 2023 Stock Incentive Plan, which occured on December 7, 2023. Not Applicable |
Non-qualified stock option
|
50,000 |
| 2023-04-20 | Coste Catherine |
Director |
Award↑
Filing footnotes — Non-qualified stock option (Direct)
Options granted to Ms. Coste in April 2023 as part of her fiscal 2023 Board compensation package. Final issuance was subject to and conditioned upon the approval by stockholders of the 2023 Stock Incentive Plan, which occured on December 7, 2023. Not Applicable |
Non-qualified stock option
|
32,000 |
| 2023-04-06 | Lu Gary |
Chief Financial Officer |
Award↑
Filing footnotes — Non-qualified stock option (Direct)
Not applicable 25% exercisable on 12/9/2023, and 25% annually there after. |
Non-qualified stock option
|
100,000 |
| 2023-01-27 | BARBIERI ALLEN |
Director, Executive Vice-Chairman |
Buy↑
Filing footnotes — Common Stock (Direct)
Open Market Purchase |
Common Stock
|
1,538 |
| 2023-01-26 | Coste Catherine |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
Open Market Purchase |
Common Stock
|
2,190 |
| 2023-01-25 | Irani Zackary S. |
Director, Chief Executive Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
Open Market Purchase |
Common Stock
|
1,800 |
| 2023-01-24 | Irani Zackary S. |
Director, Chief Executive Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
Open Market Purchase |
Common Stock
|
2,000 |
| 2021-12-09 | Sloan Steven |
Chief Financial Officer |
Award↑
Filing footnotes — Non-qualified stock option (Direct)
Not applicable 25% exercisable 12/9/2022, 25% per year exercisable there after. |
Non-qualified stock option
|
40,000 |
| 2021-12-09 | Sirgo Mark A |
Director |
Award↑
Filing footnotes — Non-qualified stock option (Direct)
Not applicable |
Non-qualified stock option
|
25,000 |
| 2021-12-09 | Irani Zackary S. |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Non-qualified stock option (Direct)
Not applicable 25% exercisable 12/9/2022, 25% per year exercisable there after. |
Non-qualified stock option
|
100,000 |
| 2021-12-09 | Emerson Jane |
Director |
Award↑
Filing footnotes — Non-qualified stock option (Direct)
Not applicable |
Non-qualified stock option
|
25,000 |
| 2021-12-09 | Coste Catherine |
Director |
Award↑
Filing footnotes — Non-qualified stock option (Direct)
Not applicable |
Non-qualified stock option
|
25,000 |
| 2021-12-09 | BARBIERI ALLEN |
Director, Executive Vice-Chairman |
Award↑
Filing footnotes — Non-qualified stock option (Direct)
Not applicable |
Non-qualified stock option
|
45,000 |
| 2020-12-10 | Emerson Jane |
Director |
Award↑
Filing footnotes — Non-qualified stock option (Direct)
Not applicable |
Non-qualified stock option
|
20,000 |
| 2020-12-10 | CANO FRANCIS |
Director |
Award↑
Filing footnotes — Non-qualified stock option (Direct)
Not applicable |
Non-qualified stock option
|
20,000 |
| 2020-12-10 | Coste Catherine |
Director |
Award↑
Filing footnotes — Non-qualified stock option (Direct)
Not applicable |
Non-qualified stock option
|
20,000 |
| 2020-12-10 | BARBIERI ALLEN |
Director, Executive Vice-Chairman |
Award↑
Filing footnotes — Non-qualified stock option (Direct)
Not applicable |
Non-qualified stock option
|
30,000 |